14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
May 02, 2019 $6.31 $6.38 $6.16 $6.28 224 695
May 01, 2019 $6.38 $6.42 $6.23 $6.34 174 220
Apr 30, 2019 $6.41 $6.50 $6.29 $6.32 185 695
Apr 29, 2019 $6.45 $6.53 $6.40 $6.43 151 435
Apr 26, 2019 $6.27 $6.47 $6.23 $6.44 174 403
Apr 25, 2019 $6.22 $6.28 $6.11 $6.25 176 786
Apr 24, 2019 $6.39 $6.44 $6.16 $6.29 173 949
Apr 23, 2019 $6.25 $6.43 $6.17 $6.37 208 601
Apr 22, 2019 $6.27 $6.32 $6.15 $6.28 185 474
Apr 18, 2019 $6.40 $6.51 $6.26 $6.28 269 183
Apr 17, 2019 $6.57 $6.57 $6.27 $6.40 286 751
Apr 16, 2019 $6.44 $6.73 $6.41 $6.58 374 523
Apr 15, 2019 $6.50 $6.54 $6.22 $6.43 335 983
Apr 12, 2019 $6.71 $6.71 $6.37 $6.44 607 968
Apr 11, 2019 $6.74 $6.89 $6.63 $6.63 487 266
Apr 10, 2019 $6.62 $6.73 $6.47 $6.73 438 091
Apr 09, 2019 $6.79 $6.96 $6.57 $6.59 450 194
Apr 08, 2019 $6.76 $6.96 $6.68 $6.81 342 294
Apr 05, 2019 $6.93 $7.04 $6.77 $6.79 498 125
Apr 04, 2019 $6.91 $7.05 $6.85 $6.87 762 077
Apr 03, 2019 $7.10 $7.11 $6.81 $6.90 733 421
Apr 02, 2019 $7.27 $7.31 $7.09 $7.10 763 118
Apr 01, 2019 $7.15 $7.29 $7.15 $7.24 314 156
Mar 29, 2019 $7.26 $7.31 $7.06 $7.11 352 552
Mar 28, 2019 $7.21 $7.34 $7.16 $7.19 305 536
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT